About the Community Clinical Oncology Program (CCOP)
The Community Clinical Oncology Program (CCOP) is a comprehensive clinical trials network for distributing the latest cancer prevention, control, symptom management and treatment findings to the community. Created in 1983 by the National Cancer Institute (NCI), the 47 currently funded CCOPs represent 340 hospitals and 2,900 physicians across the country, the District of Columbia and Puerto Rico. CCOPs work collaboratively with medical centers, medical oncologists, radiation oncologists, surgeons and other specialists to provide patients access to quality clinical trials. Participation is limited to medical centers that have met the highest standards of excellence in conducting cancer clinical trials.
The mission of the CCOP Program is to link patients in their communities with leading clinical cooperative groups and large cancer treatment centers located throughout the United States and Canada. These links provide state-of-the-art cancer treatments that can now be offered through your community hospitals.
About the MCRC CCOP Program
The Michigan Cancer Research Consortium is a well-established CCOP. This program was funded by the NCI in 1994. It was first established at Saint Joseph Mercy Hospital in Ann Arbor, Michigan. The CCOP continues to expand its program and add new component hospitals. The following leading Michigan health centers include Allegiance Health System in Jackson, Genesys-Hurley Cancer Institute in Flint, St. John Hospital and Medical Center in Detroit, St. John Macomb-Oakland in Warren, Sparrow Hospital in Lansing, Saint Mary's of Michigan in Saginaw, St. Joseph Mercy Oakland in Pontiac, St. Mary Mercy in Livonia, and Mercy Hospital in Port Huron. MCRC-CCOP has also expanded to include St. Francis Hospital and Medical Center in Hartford, Connecticut and St. Alphonsus Regional Medical Center in Boise, Idaho.
A leader in the National Cancer Institute's Clinical Cooperative Group Program is the North Central Cancer Treatment Group (NCCTG). NCCTG is located at the Mayo Cancer Center in Rochester, Minnesota. It is our primary regional research base for clinical trials. Because of our affiliation, physicians, scientists and other staff members from the Mayo Cancer Center are available to consult with our physicians and researchers at any time. In addition, the Michigan Cancer Research Consortium CCOP staff meet regularly with doctors and nurses from other parts of the United States to review current research and assist in the development of new clinical trials.
The Michigan Cancer Research Consortium CCOP is also affiliated with other research bases throughout the United States and Canada. These include:
- Eastern Cooperative Oncology Group (ECOG)
- Radiation Therapy Oncology Group (RTOG)
- National Surgical Adjuvant Breast and Bowel Project (NSABP)
- Southwest Oncology Group (SWOG)
- Gynecology Oncology Group (GOG)
- Cancer Trials Support Unit (CTSU)
- MD Anderson CCOP Research Base (MDA)
- Wake Forest University (WFU)
- Alliance for Clinical Trials in Oncology
This broad-based research consortium links us with the most current research activities in the area of cancer treatment and prevention around the country.
[ back to top ]